ライフサイエンスコーパス: conflict of interest

1 licts of interest and 61% for more intrinsic conflicts of interest).

2 practice, especially when there is potential conflict of interest.

3 for which there could be any perception of a conflict of interest.

4 ing concerns about intellectual property and conflict of interest.

5 nteraction between two organisms that have a conflict of interest.

6 of 29 (17%) among those without a financial conflict of interest.

7 ommon, a practice that has the potential for conflict of interest.

8 ir guidelines manage both real and perceived conflict of interests.

9 aluating therapies and identifying potential conflicts of interest.

10 reviews and reviews whose authors disclosed conflicts of interest.

11 octoring family members because of potential conflicts of interest.

12 formation about authors' potential financial conflicts of interest.

13 es did not mention anything about funding or conflicts of interest.

14 ns involved in running a trial had intrinsic conflicts of interest.

15 have the potential of creating institutional conflicts of interest.

16 licts of interest as compared with financial conflicts of interest.

17 anied by increasing concerns about financial conflicts of interest.

18 ucted on investigator training and potential conflicts of interest.

19 t company, both of which could be considered conflicts of interest.

20 Some view these payments as conflicts of interest.

21 closure, review, and management of financial conflicts of interest.

22 encies in order to analyze their policies on conflicts of interest.

23 n, clear, specific, and credible policies on conflicts of interest.

24 tutions--reported that they had no policy on conflicts of interest.

25 at they had policies requiring disclosure of conflicts of interest.

26 n improve the integrity of science or manage conflicts of interest.

27 eing mindful of the importance of minimizing conflicts of interest.

28 cy, monitoring of actions, and management of conflicts of interest.

29 ves and provided disclosure of any potential conflicts of interest.

30 gn, and the involvement of stakeholders with conflicts of interest.

31 he primary studies than those with financial conflicts of interest.

32 these drugs than reviewers without financial conflicts of interest.

33 tial bias-is a popular solution for managing conflicts of interest.

34 Only half the CPG panels addressed conflicts of interest.

35 uniclonal, minimizing within-cluster genetic conflicts of interest.

36 d the documentation of funding and potential conflicts of interest.

37 phase clinical trials perceive investigator conflicts of interests.

38 WHO credibility, particularly with regard to conflicts of interest; (2) views were mixed on whether W

39 mong assessments associated with a financial conflict of interest, 7 of 8 (88%) were classified as fa

40 Conflicts of interest about where to go and what to do a

41 authorization, disclosure or prohibition of conflicts of interest, additional safeguards for sensiti

42 ther physicians and scientists who have such conflicts of interest adequately disclose such relations

43 he greatest transparency regarding potential conflicts of interest, all members of the Joint Task For

44 he greatest transparency regarding potential conflicts of interest, all members of the JTFPP and the

45 ing transparency and management of financial conflicts of interest among committees that develop guid

46 Wide variation in management of conflicts of interest among institutions may cause unnec

47 heir attitudes regarding potential financial conflicts of interest among researchers and medical cent

48 rocal parasitisms, which can be disrupted by conflicts of interest among the partners.

49 of D. discoideum is partly competitive, with conflicts of interests among cells.

50 tients on research trials (52% for financial conflicts of interest and 61% for more intrinsic conflic

51 versight system to protect against financial conflicts of interest and about researchers' financial i

52 mplemented consistently in order to mitigate conflicts of interest and address such interactions' pot

53 ey that addressed multiple issues related to conflicts of interest and research participation.

54 sed adequacy of blinding, 18 (53%) disclosed conflicts of interest, and 19 (56%) received funding fro

55 tential model biases, 52% failed to disclose conflicts of interest, and 74% failed to describe method

56 erventions are beneficial, address potential conflicts of interest, and be available to persons who c

57 will be more prone to anger, prevail more in conflicts of interest, and consider themselves entitled

58 Sloppiness, oversights, conflicts of interest, and failure to share were less se

59 ties of clinicians harbor concerns regarding conflicts of interest, and many are uncertain of the pra

60 ving access to and quality of care, managing conflicts of interest, and professional self-regulation.

61 articles should disclose potential financial conflicts of interest, and readers of review articles sh

62 ionships, however, often produce significant conflicts of interest, and recent attention has focused

63 assessment of depression, severity, reported conflicts of interest, and study quality.

64 ollowed a written protocol, had no disclosed conflicts of interest, and were blinded to all study hyp

65 management of potential impacts of financial conflicts of interest; and 3) transparency in research m

66 Conflicts of interest are known to create problems for t

67 tiple eggs are laid into a host, inter-clone conflicts of interest arise.

68 Conflicts of interest arising from these ties can influe

69 more, concerned about traditional intrinsic conflicts of interest as compared with financial conflic

70 re professionals and scientists also present conflicts of interest, as does the dual purpose for the

71 miRNAs to represent both a means to resolve conflicts of interest, as well as instigate them.

72 l discuss and resolve all relevant potential conflicts of interest associated with this selection.

73 l discuss and resolve all relevant potential conflicts of interest associated with this selection.

74 Disclosures of conflicts of interest at drug advisory committee meeting

75 Policies governing conflicts of interest at leading medical schools in the

76 e is substantial variation among policies on conflicts of interest at medical schools and other resea

77 We analyzed policies governing conflicts of interest at the 10 medical schools in the U

78 tead viewed as an outcome of an intragenomic conflict of interest between an individual's genes.

79 ups experience time pressure and significant conflict of interest between members (due to various bet

80 a that natural selection drives intragenomic conflicts of interest between genes originating from dif

81 on about parent of origin plays in mediating conflicts of interest between genes residing in the same

82 Conflicts of interest between physicians' commitment to

83 g games that range from interactions without conflicts of interest between the players to interaction

84 cations for sexual selection, speciation and conflicts of interest between the sexes, and yet they ar

85 industry and academia, other issues, such as conflicts of interest (both real and perceived), continu

86 most exclusively on disclosures of financial conflicts of interest but little is known about how disc

87 Responses to these conflicts of interest by medical institutions, journals,

88 Conflicts of interest can arise from other financial tie

89 Although both financial and intrinsic conflicts of interest can exist throughout the drug deve

90 inated duets when responding to rival pairs, conflicts of interest caused duet coordination to break

91 t adverse outcomes related to poorly managed conflict of interest (COI) in research, education, and c

92 earch has resulted in increased reporting of conflicts of interest (COI).

93 itors statement on sources of funding and/or conflicts of interest (COI).

94 The landscape of managing potential conflicts of interest (COIs) has evolved substantially a

95 Conflicts of interest (COIs) have been defined by the Am

96 Conflicts of interest (COIs) may influence medical liter

97 institutional review board and institutional conflict of interest committee.

98 itutional review board and the institutional conflict of interest committee.

99 t guidance requiring more detailed financial conflict of interest disclosure at advisory committee me

100 orkgroups will complete a standard potential conflict of interest disclosure form, which will be avai

101 orkgroups will complete a standard potential conflict of interest disclosure form, which will be avai

102 The actual impact of conflict of interest disclosure to research subjects nee

103 In this study of self-reported conflict-of-interest disclosure by physicians at a large

104 tunity to assess the accuracy of physicians' conflict-of-interest disclosures.

105 nvolvement in p53 research and the potential conflict of interest discussed here demonstrate the need

106 o participate, and to assure the public that conflicts of interest do not compromise either patient s

107 ders to form their own opinions on whether a conflict of interest exists and what relevance that has

108 Furthermore, conflict of interest exists for Web-based firms because

109 sician-patient relationship, and 52% believe conflict of interest exists.

110 Associations between financial conflicts of interest, favorability assessments, and pre

111 nced by the authors' self-declared financial conflicts of interest (FCOI).

112 Importance: Financial conflicts of interest (FCOIs) among authors of clinical

113 nclear whether global experts with financial conflicts of interest (FCOIs) should be included in, be

114 Here we explore author financial conflicts of interest (FCOIs), sources of guideline fund

115 s been observed among members with financial conflicts of interest (FCOIs).

116 omedical researchers and industry (financial conflicts of interest [FCOIs]) on research prominence.

117 ship, including important issues relating to conflict of interest for both academic and industry part

118 Potential conflicts of interest for clinician-investigators includ

119 panel composition, decision-making process, conflicts of interest, guideline objective, development

120 To meet that need, we propose conflict of interest guidelines for individual biomedica

121 ng Principles has, in this article, proposed conflict-of-interest guidelines regarding industry fundi

122 f the body of evidence relating to financial conflicts of interest has been performed.

123 Concerns about conflicts of interest have driven a wedge between academ

124 policy recommendations addressing financial conflicts of interest have focused on the role of academ

125 to challenges associated with institutional conflicts of interest (ICOI).

126 Most policies on conflict of interest in our sample of major research ins

127 keting activities adequately disclosed their conflict of interest in subsequent journal publications.

128 cal and tobacco companies, which can cause a conflict of interest in the development and marketing of

129 dvisory panel recommended managing perceived conflicts of interest in 26% of the cases, including rec

130 n substantially inform ongoing discussion on conflicts of interest in clinical research.

131 ncies had policies that explicitly addressed conflicts of interest in extramural research, and all bu

132 lection to use bargaining tactics to resolve conflicts of interest in favor of the angry individual.

133 Despite federal regulations on faculty conflicts of interest in federally funded research, acad

134 The mainstay for addressing conflicts of interest in health care is disclosure of pe

135 Given scrutiny over financial conflicts of interest in health care, it is important to

136 s throughout the trial process and minimizes conflicts of interest in individual industry relationshi

137 search on the prevalence and consequences of conflicts of interest in medicine, little attention has

138 Conflicts of interest in research can affect a company's

139 al, and empirical studies of objectivity and conflicts of interest in scientific research, we propose

140 This article focuses on the analysis of conflicts of interest in the conduct of clinical trials

141 eration between conspecific individuals with conflicts of interest (including non-kin) can be strateg

142 ore likely to achieve CRC than those without conflict of interest (individual procedure analysis [OR

143 ns of wine value and quality illustrates how conflicts of interest influence decisions about adaptive

144 It is well documented that financial conflicts of interest influence medical research and cli

145 ling to participate in trials after learning conflict of interest information (63%).

146 Patients generally believed that conflict of interest information should be disclosed to

147 e likely to report favorable findings when a conflict of interest is declared.

148 actual compliance with reporting a potential conflict of interest is unable to be determined, the val

149 fe Studies in Transplantation," "Ethical and Conflict of Interest Issues Between Sponsors and Investi

150 es methods to manage, minimize, or eliminate conflict of interest issues, including identification an

151 tion that the main problems are researchers' conflict of interest, lack of institutional review board

152 ur problem areas: sensationalism, biases and conflicts of interest, lack of follow-up, and stories th

153 eans may be problematic because of financial conflicts of interest, lack of patient authorization, in

154 about the Dead Donor Rule, the potential for conflict of interest, making donation happen, and the ca

155 lementing efficient, effective approaches to conflict of interest management.

156 Predetermined conflict-of-interest management strategies were applied,

157 Conflict of interest may arise when 1 physician serves 2

158 A conflict of interest may indeed result, though not in al

159 Institutional financial conflicts of interest may affect research results.

160 Reviewers with financial conflicts of interest may be more likely to present evid

161 Industry funding and financial conflicts of interest may contribute to bias in the synt

162 ients expressed more concern about financial conflicts of interest may have the potential to influenc

163 nt, demarcating responsibilities, minimizing conflict of interest, meeting community expectations, an

164 tion, and case review; 6) abuse of power and conflicts of interest must be avoided; 7) ethics consult

165 determine the effect of author disclosure of conflict of interest on scientific reporting.

166 ness about the potential impact of financial conflicts of interest on biomedical research, no compreh

167 nfluence of private sector actors with major conflicts of interest on public policy development, and

168 There is substantial concern that financial conflicts of interest on the part of investigators condu

169 The impact of the removal of persons with conflicts of interest on the vote margins was also evalu

170 al review board as well as to a committee on conflicts of interest or a university official.

171 birth more than doubled in studies reporting conflicts of interest (OR, 2.50; 95% CI, 1.70-3.67; 5 st

172 guidelines lack transparency, are tainted by conflicts of interest, or fail to employ rigorous method

173 Content of the conflict of interest policies varied widely across insti

174 Conflicts of interest policies have become a part of the

175 Society of Clinical Oncology's (ASCO's) new conflict of interest policy reflects a commitment to tra

176 A formal conflict of interest policy was developed at the onset o

177 adherence to the American Heart Association conflict of interest policy was maintained throughout th

178 cademy of Sciences (NAS) developed its first conflict of interest policy, requiring committee members

179 Institute on Medicine as a Profession (IMAP) Conflicts of Interest Policy Database score.

180 Conflicts of interest pose a threat to the integrity of

181 g concerns highlighted include standards for conflict of interest, recruitment and remuneration pract

182 Yet accumulating 'conflict of interest' regulations in academic health cen

183 ntaining professional boundaries (minimizing conflict of interest, respecting shared decision-making,

184 dentiality, fiduciary obligations (including conflicts of interest), responsibilities arising from pa

185 Most patients reported that potential conflicts of interest should be disclosed to patients on

186 In an effort to regulate physician conflicts of interest, some US academic medical centers

187 Furthermore, if only studies including a conflict of interest statement were included (66 of 81),

188 Annually, all members completed conflict of interest statements; no conflicts were ident

189 e that there is an appropriate way to handle conflicts of interest stemming from relationships with i

190 unding agencies do not require disclosure of conflicts of interest, suggests that the current standar

191 s expressed more concern regarding financial conflict of interest than older patients (odds ratio, 6.

192 The article also discusses the potential conflicts of interest that can arise when clinicians sta

193 n, the authors first identified and analyzed conflicts of interest that may affect the activities, le

194 scrutiny in recent years because they create conflicts of interest that pose a risk of biasing the ju

195 types of pressures, misguided thinking, and conflicts of interest that sometimes led their predecess

196 nters would take the lead in eliminating the conflicts of interest that still characterize the relati

197 ations have become blurred and this produces conflicts of interests that have led to this crisis of t

198 m to test a prevailing idea in the domain of conflict-of-interest: that expertise in a domain insulat

199 to which Committee members are screened for conflicts of interest, the workgroups that gather inform

200 Because of the potential for conflicts of interest to lead to biased judgments, the 2

201 esearch institutions report the existence of conflicts of interest to the funding agency but allow th

202 Financial conflicts of interest, ubiquitous in cardiovascular medi

203 A consistent method for addressing potential conflict of interest was followed if task force members

204 In 79%, a related conflict of interest was reported.

205 % CI = 0.45, 0.71]), as well as studies with conflict of interest were more likely to achieve CRC tha

206 Until the 1960s, concerns about conflicts of interest were confined to scientists who se

207 Financial conflicts of interest were identified using the index re

208 Reviewers without financial conflicts of interest were more likely to include statem

209 Conflicts of interest were not reported in 16 of the 20

210 There is particular risk for conflict of interest when economic partnerships extend b

211 between cells will frequently be subject to conflicts of interest when they occur between unrelated

212 ed in running a clinical trial had financial conflicts of interest, whereas 65% of patients would be

213 rs as much as senior partners and be wary of conflicts of interest with venture capital entrepreneurs